Clinical trialNCT04294264Active, not recruitingPhase 2Interventional

TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer

SponsorRutgers, The State University of New JerseyEnrollment50Metastatic Colorectal CarcinomaRecurrent Colon CarcinomaRefractory Colorectal CarcinomaStage IV Colon Cancer AJCC v7Stage IVA Colon Cancer AJCC v7Stage IVB Colon Cancer AJCC v7

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Howard S Hochster
Rutgers Cancer Institute of New Jersey
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Trinitas Hospital and Comprehensive Cancer Center
Elizabeth, New Jersey, United States
Rwjbarnabas Health - Monmouth Medical Center Southern Campus
Lakewood, New Jersey, United States
Saint Barnabas Medical Center
Livingston, New Jersey, United States
Rwjbarnabas Health - Monmouth Medical Center
Long Branch, New Jersey, United States
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
Rwjbarnabas Health - Community Medical Center
Toms River, New Jersey, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 12 Feb 2019
Primary completion: 27 Mar 2024
Completion: 27 Mar 2026
Last update posted: 18 Nov 2024
Registered enrollment: 50
Registry id: NCT04294264

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.